
Mesenchymal tumors of the mediastinum are exceedingly rare, accounting for only approximately 2–6% of all mediastinal neoplasms [1]. Except for certain exceptions, mediastinal soft tissue tumors display histological and molecular features largely analogous to those of their counterparts in other...

The purpose of this study was to design a radiogenomics machine learning-DeepSurv model for biochemical recurrence-free (BCR-free) survival and treatment response (TR) prediction for radiotherapy (RT) of prostate cancer (PCa). In this study, radiomic features were extracted from pre and post treatment...

Breast cancer (BC) is the second most common malignant neoplasm globally, and it ranks fifth as a cause of death [1]. Neoadjuvant chemotherapy (NAC) can reduce patient’s primary tumor burden and the extent of nodal involvement, which may increase the likelihood of breast-conserving surgery and...

Breast cancer is a prevalent malignant tumor among women worldwide, accounting for 11.6% of new cases annually [1]. Human epidermal growth factor receptor 2 (HER-2) is a significant factor influencing the prognosis of patients with breast cancer. It is a crucial gene target for breast cancer treatment...

Nasopharyngeal carcinoma (NPC) shows a markedly higher incidence in endemic regions––especially China and Southeast Asia––but remains relatively rare in Western populations [1, 2]. Its global incidence and mortality are projected to increase substantially by 2040, particularly...